FDA Orange Book
Is there a generic for Iomervu?
Iomervu contains iomeprol. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Iomervu (iomeprol). The Orange Book shows its last listed exclusivity ends November 27, 2029.
Run it in Rivvi
Map Iomervu and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Iomervu products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, intra-arterial | 15GM IODINE/50ML (300MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intra-arterial | 17.5GM IODINE/50ML (350MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intra-arterial | 20GM IODINE/50ML (400MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intra-arterial | 25GM IODINE/100ML (250MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intra-arterial | 30GM IODINE/100ML (300MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intra-arterial | 35GM IODINE/100ML (350MG IODINE/ML) | Marketed (Rx) | None | 0 | None |
| solution, intra-arterial | 40GM IODINE/100ML (400MG IODINE/ML) | Marketed (Rx) | None | 0 | None |
| solution, intra-arterial | 45GM IODINE/150ML (300MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intra-arterial | 52.5GM IODINE/150ML (350MG IODINE/ML | Discontinued | None | 0 | None |
| solution, intra-arterial | 60GM IODINE/150ML (400MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intra-arterial | 60GM IODINE/200ML (300MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intra-arterial | 70GM IODINE/200ML (350MG IODINE/ML) | Marketed (Rx) | None | 0 | None |
| solution, intra-arterial | 80GM IODINE/200ML (400MG IODINE/ML) | Marketed (Rx) | None | 0 | None |
| solution, intravenous | 15GM IODINE/50ML (300MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 17.5GM IODINE/50ML (350MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 20GM IODINE/50ML (400MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 25GM IODINE/100ML (250MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 30GM IODINE/100ML (300MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 35GM IODINE/100ML (350MG IODINE/ML) | Marketed (Rx) | None | 0 | None |
| solution, intravenous | 40GM IODINE/100ML (400MG IODINE/ML) | Marketed (Rx) | None | 0 | None |
| solution, intravenous | 45GM IODINE/150ML (300MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 52.5GM IODINE/150ML (350MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 60GM IODINE/150ML (400MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 60GM IODINE/200ML (300MG IODINE/ML) | Discontinued | None | 0 | None |
| solution, intravenous | 70GM IODINE/200ML (350MG IODINE/ML) | Marketed (Rx) | None | 0 | None |
| solution, intravenous | 80GM IODINE/200ML (400MG IODINE/ML) | Marketed (Rx) | None | 0 | None |
NDA 216016, 216017, held by BRACCO DIAGNOSTICS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Iomervu exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | November 27, 2029 | 216016 |
Iomervu NDC codes
Questions
Is there a generic for Iomervu?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Iomervu (iomeprol). The Orange Book shows its last listed exclusivity ends November 27, 2029.
What is the generic name for Iomervu?
The active ingredient in Iomervu is iomeprol, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.